Editorial: timing of carvedilol - promoting survivors in cirrhosis

Aliment Pharmacol Ther. 2022 Jul;56(1):172-173. doi: 10.1111/apt.16942.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Carvedilol / therapeutic use
  • Esophageal and Gastric Varices*
  • Humans
  • Liver Cirrhosis* / drug therapy
  • Survivors

Substances

  • Carvedilol